Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease

Daniele Orsucci1, Michelangelo Mancuso, Elena Caldarazzo Ienco

  • 1Department of Neuroscience, Neurological Clinic, University of Pisa, Via Roma 67, 56126 Pisa, Italy. d.orsucci@sssup.it

Insights

Alzheimer's disease (AD) pathogenesis involves complex vascular factors and mitochondrial dysfunction. This review explores the link between vascular issues and mitochondrial problems in AD, highlighting their role in disease development.

Area of Science:

  • Neurology
  • Genetics
  • Pathophysiology

Background:

  • Alzheimer's disease (AD) pathogenesis is multifactorial, with genetics playing a role in a minority of cases.
  • Vascular risk factors like atherosclerosis and stroke are increasingly linked to AD development.
  • Oxidative damage and mitochondrial dysfunction are implicated, but their precise role in AD onset versus consequence is debated.

Purpose of the Study:

  • To review the connection between vascular factors and mitochondrial dysfunction in Alzheimer's disease pathogenesis.
  • To explore how vascular issues may initiate or exacerbate AD pathology.
  • To synthesize current evidence on the interplay between cerebrovascular health and cellular energy metabolism in AD.

Main Methods:

  • Literature review of studies investigating Alzheimer's disease, vascular factors, and mitochondrial dysfunction.
  • Analysis of genetic associations, including the apolipoprotein E gene.
  • Examination of evidence linking chronic hypoperfusion to oxidative stress and mitochondrial impairment.

Main Results:

  • Apolipoprotein E gene is a significant vascular susceptibility factor in sporadic late-onset AD.
  • Chronic hypoperfusion may trigger mitochondrial dysfunction in vascular cells.
  • Mitochondrial dysfunction can enhance reactive oxygen species production, potentially contributing to AD pathology.

Conclusions:

  • Vascular factors are critically involved in Alzheimer's disease pathogenesis.
  • Mitochondrial dysfunction, potentially triggered by vascular issues, plays a key role in AD.
  • Understanding the vascular-mitochondrial link is crucial for developing effective AD therapies.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...